INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹1,566 Cr | ₹1,581 Cr | ₹1,383 Cr | ₹1,215 Cr | ₹1,023 Cr |
What is the latest Total Expenditure of INDOCO REMEDIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹1,566 Cr |
| Mar2024 | ₹1,581 Cr |
| Mar2023 | ₹1,383 Cr |
| Mar2022 | ₹1,215 Cr |
| Mar2021 | ₹1,023 Cr |
How is Total Expenditure of INDOCO REMEDIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,566 Cr | -0.96 | |
| Mar2024 | ₹1,581 Cr | 14.34 | |
| Mar2023 | ₹1,383 Cr | 13.84 | |
| Mar2022 | ₹1,215 Cr | 18.70 | |
| Mar2021 | ₹1,023 Cr | - | |
Compare Total Expenditure of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,404.6 Cr | -3% | -9.1% | -14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 2.8% | 6.6% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -0.2% | -0.7% | 10.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | -0.2% | 8.1% | 21.8% | Stock Analytics | |
| CIPLA | ₹124,094.0 Cr | 1.4% | -1.4% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 2.7% | 1% | -3.4% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -3% |
-9.1% |
-14.5% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses